Tagged Articles

Auxilium Pharmaceuticals 39 articles

Testosterone cases tossed from MDL for lack of information

U.S. District Judge Matthew Kennelly threw out 160 cases from a multidistrict litigation (MDL) involving cardiovascular risks with testosterone replacement therapies because they failed to provide more information about their use of the products, how they obtained them, and their alleged injuries. “The failure of these plaintiffs to produce discovery is prejudicial to the defendants in these cases because it hinders the investigation and preparation of a defense in these cases,” Judge Kennelly wrote. He also suggested more dismissals may be ordered down the line. The dismissal of 160 cases makes a small impact on the multidistrict litigation, where more ... Read More

Three drug makers reach tentative settlement in testosterone side effects MDL

Three manufacturers of testosterone replacement therapies among several in a multidistrict litigation accusing the companies of failing to warn consumers about cardiovascular risks with their products, have notified an Illinois federal judge that they have reached a tentative deal to settle the cases in which they are named. U.S. District Judge Matthew Kennelly told the manufacturers – Endo Pharmaceuticals Inc., Auxilium Pharmaceuticals LLC and GlaxoSmithKline LLC – that he would place a 45-day stay on the cases against them while the details of the settlement are worked out. He also told the remaining defendants – including AbbVie Inc., and Actavis ... Read More

PA schedules 17 testosterone side effects trials through January 2019

Days after Auxilium Inc., settled a lawsuit over claims its testosterone treatment caused an Alabama man to suffer a stroke, a Philadelphia Court of Common Pleas judge scheduled 17 testosterone side effects trials involving multiple testosterone makers to take place between June and January 2019. The Auxilium trial was scheduled to begin Jan. 8, and was filed in 2014. Philadelphia Court of Common Pleas Judge John M. Younge had planned to schedule seven bellwethers during that timeframe, paving the way for a settlement of the nearly 30 cases pending in the court. But instead of making good on a previous ... Read More

Auxilium settles testosterone side effects case before trial

Days before Auxilium Pharmaceuticals Inc., was scheduled to go to court over claims that its testosterone replacement therapy Testim caused an Alabama man to suffer a stroke, the drug company announced it had settled with the plaintiff, the terms of which have not been disclosed. The lawsuit was brought by Robert Hoehl and his wife Kathleen, and the trial was scheduled to begin Jan. 8. At one point, the case was positioned as the lead in a proposed mass tort over testosterone side effects. Hoehl sued Auxilium in 2014 alleging that in October 2011, at the age of 62, he ... Read More

Several testosterone side effects trials scheduled through 2019

Three trials involving testosterone side effects have taken place in 2017 and another 10 or 11 cases are scheduled to be tried through 2019, due to U.S. District Judge Matthew Kennelly’s interest in ensuring all plaintiffs and defendants have the benefit of timely bellwethers. The multidistrict litigation is consolidated in the U.S. District Court for the Northern District of Illinois and names a handful of testosterone manufacturers including AbbVie Inc., Eli Lilly & Co., and Auxilium Pharmaceuticals Inc. There are also state cases by Illinois residents against AbbVie. The Cook County judge is coordinating with Judge Kennelly on those cases. ... Read More

Testim testosterone side effects trial scheduled for January

Philadelphia County Court of Common Pleas Judge Mary Colins denied Auxilium Pharmaceuticals Inc.’s request to worm out of an upcoming trial over alleged testosterone side effects linked to its hormone replacement drug Testim. Auxilium had cited federal preemption as a grounds for summary judgment. The trial involves the case of Alabama resident Robert Hoehl and his wife Kathleen. Hoehl sued Auxilium in 2014 alleging that in October 2011, at the age of 62, he was prescribed Testim to treat fatigue and erectile dysfunction related to low testosterone. But in July 2012, Hoehl suffered a stroke, which he believes was caused ... Read More

Auxilium escapes verdict in testosterone side effects trial

Auxilium Pharmaceuticals Inc., maker of the testosterone replacement therapy Testim, escaped a verdict in the first bellwether trial blaming Testim for a man’s heart attack. This marks the first victory in multidistrict litigation (MDL) over testosterone side effects that names several testosterone manufacturers. The first two bellwether trials were against AbbVie Inc., makers of AndroGel, and resulted in combined $290 million in verdicts. The seven-day trial focused on the case of Steve Holtsclaw, who claimed he was prescribed Testim after complaining to his doctor about chronic fatigue. Months after treatment, Holtsclaw suffered a heart attack. He since learned that studies ... Read More

Testim benefits not worth the heart attack, patient says

Steve Holtsclaw’s heart attack in 2014 weighs on his mind daily. He’s more emotional now, and constantly wonders, “How much longer have I got?” the 62-year-old man told an Illinois federal jury during the first bellwether trial in a multidistrict litigation (MDL) involving cardiovascular risks with Auxilium Pharmaceuticals Inc.’s testosterone replacement therapy Testim. Holtsclaw was prescribed Testim in 2013 after complaining to his doctor about chronic fatigue. A blood test showed his testosterone levels were low. Months later, Holtsclaw suffered a heart attack. He received two stents and was put on several medications to help prevent a second heart attack. ... Read More

Auxilium to take hot seat in latest testosterone side effects trial

Weeks after two juries handed down multi-million verdicts to two men who claimed that AbbVie Inc., did not adequately warn of cardiovascular risks with its testosterone replacement therapy AndroGel, drug maker Auxilium Pharmaceuticals LLC will take the hot seat in court over allegations that its testosterone treatment Testim caused a man to suffer a heart attack. Steve Holtsclaw is one of thousands of men alleging manufacturers of testosterone replacement therapy misrepresented what their products were safe and effective to treat while failing to warn that the drugs increased the risk of heart attacks, strokes and blood clots. Holtsclaw claimed he ... Read More

Testosterone makers fight proposed class action lawsuit

Endo Pharmaceuticals and its unit Auxilium Pharmaceuticals LLC filed a motion to compel compliance against UnitedHealthcare (UHC) in an Illinois federal court, arguing that the insurance company should hand over subpoenaed information about its dealings with testosterone replacement therapies if it wants to be part of a proposed class of insurers and third-party payors accusing testosterone manufacturers of fraudulently marketing the drugs. UHC isn’t a party in the litigation but is the largest member of the proposed class, making its information key to Endo and Auxilium, which are fighting against certification. But UHC has been avoiding calls, not returning messages, ... Read More